Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 09/07/2027
This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bio...
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
$500,000
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 01/07/2027
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science ...
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 01/07/2026
This Notice of Funding Opportunity (NOFO) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that ...
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
$200,000
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 01/07/2026
This Notice of Funding Opportunity (NOFO) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that ...
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 01/07/2028
The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorb...
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 09/07/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as ...
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/14/2024
DUE: 09/28/2026
The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat centra...
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 09/28/2026
The purpose of this announcement is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disor...
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 10/25/2027
The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, sc...
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 10/25/2027
The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, s...